ICU Medical Q1 revenue up 5% to $568.6M; GAAP loss narrows to $(0.41) from $(1.61)

ICU MEDICAL INC/DE

2023-Q1 EPS reported -$0.41 revenue$568,649,000

Revenue $568.6M vs $543.1M YoY; GAAP gross margin 34% vs 31%.
GAAP net loss $(9.8)M ($(0.41)/diluted share) vs $(38.1)M ($(1.61)) a year ago.
Adjusted diluted EPS $1.74 (down from $1.82); adjusted EBITDA $102.0M vs $84.9M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

ICU MEDICAL INC/DE reported the quarter ended March 31, 2023 results: revenue $568.6 million, net income $(9.8) million, EPS $(0.41) per diluted share.

Period: the quarter ended March 31, 2023
Revenue: $568.6 million
Net income: $(9.8) million
EPS: $(0.41) per diluted share
Result: reported results

Exact text from the filing

First quarter 2023 revenue was $568.6 million, compared to $543.1 million in the same period last year. GAAP gross profit for the first quarter of 2023 was $192.0 million, as compared to $168.8 million in the same period last year. GAAP gross margin for the first quarter of 2023 was 34%, as compared to 31% in the same period last year. GAAP net loss for the first quarter of 2023 was $(9.8) million, or $(0.41) per diluted share, as compared to GAAP net loss of $(38.1) million, or $(1.61) per diluted share, for the first quarter of 2022.

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

ICU MEDICAL INC/DE filing history →

Source: SEC EDGAR

accession 0000883984-23-000020

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.